News Detail
New Delhi, 25 Nov 2024: The government may soon add provisions with the Drugs Rules, 1945 facilitating the industry to apply for manufacturing licence for stem cell derived products, gene therapy products, among others, with the State Licensing Authorities (SLA) and Central Licen......
View Details
Source : Pharmabiz
Drugs Rules
stem cell
gene therapy
SLA
Central Licences Approval Authority
CLAA
r-DNA
DTAB
xenographs
Drugs & Cosmetics Act
LVPs
Form 27D
Related News
- Illegal cough syrup worth Rs 5 Crore seized at Assam-Tripura border (08-12-2024)
- Tragedy at Hyderabad Pharma: NGT Orders Accountability (08-12-2024)
- Experts Call for Urgent Standardisation and Quality Control of Herbal Medicines (08-12-2024)
- Experts Warn Against OTC Creams for Skin Issues: Potential Harm from Steroid Use (08-12-2024)
- Expert team will probe maternal deaths in Ballari hospital: Health Minister (08-12-2024)
- Maha FDA finds spurious drugs at rural GMCH in Beed, FIR against 4 suppliers (08-12-2024)
- CDSCO waives local clinical trials for new drugs approved in the USA, UK, Japan, Australia, Canada and EU: Govt in LS (07-12-2024)
- NDPS Act: SC explains law on presence of gazetted officer during search (07-12-2024)
- Contraband cough syrup seized from Tejas Rajdhani express (07-12-2024)
- Government has taken several measures to encourage domestic manufacturing: Govt in LS (07-12-2024)